Unknown

Dataset Information

0

Effects of Epstein-Barr Virus Infection on CD19+ B Lymphocytes in Patients with Immunorelated Pancytopenia.


ABSTRACT: Objectives:To explore effects of Epstein-Barr virus (EBV) infection on CD19+ B lymphocytes in patients with immunorelated pancytopenia (IRP). Methods:An enzyme-linked immunosorbent assay (ELISA) in vitro diagnostic kit was used to detect EBV capsid antigen- (CA-) IgG and VCA-IgM antibodies in the serum. We analyzed the EBV-DNA copies of CD19+ B lymphocyte by using real-time quantitative polymerase chain reaction (RT-qPCR). CD21, CD23, CD5, CD80, and CD86 receptors on the surfaces of CD19+ B cells were detected by flow cytometry (FCM). The correlation between these receptors and EBV-DNA copies were evaluated. Results:The results revealed that the positive rate of EBVCA-IgM and CD19+ B lymphocyte EBV-DNA copy in the IRP group were significantly higher than those in the control group (P < 0.05). CD19+ B lymphocyte EBV-DNA copies were also more abundant in IRP patients than in control subjects (P < 0.05). CD19+ B lymphocyte EBV-DNA copies were also more abundant in IRP patients than in control subjects (P < 0.05). CD19+ B lymphocyte EBV-DNA copies were also more abundant in IRP patients than in control subjects (. Conclusions:EBV infection may activate CD19+ B lymphocytes and further disrupt bone marrow hematopoiesis in IRP patients.

SUBMITTER: Zhao Y 

PROVIDER: S-EPMC7048940 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of Epstein-Barr Virus Infection on CD19+ B Lymphocytes in Patients with Immunorelated Pancytopenia.

Zhao Yang Y   Wang Yihao Y   Liu Hui H   Ding Kai K   Liu Chunyan C   Yu Hong H   Shao Zonghong Z   Fu Rong R  

Journal of immunology research 20200217


<h4>Objectives</h4>To explore effects of Epstein-Barr virus (EBV) infection on CD19+ B lymphocytes in patients with immunorelated pancytopenia (IRP).<h4>Methods</h4>An enzyme-linked immunosorbent assay (ELISA) in vitro diagnostic kit was used to detect EBV capsid antigen- (CA-) IgG and VCA-IgM antibodies in the serum. We analyzed the EBV-DNA copies of CD19+ B lymphocyte by using real-time quantitative polymerase chain reaction (RT-qPCR). CD21, CD23, CD5, CD80, and CD86 receptors on the surfaces  ...[more]

Similar Datasets

| S-EPMC6690029 | biostudies-literature
| S-EPMC6580941 | biostudies-literature
| PRJNA794826 | ENA
| S-EPMC5842224 | biostudies-literature
| S-EPMC7144007 | biostudies-literature
| S-EPMC189923 | biostudies-other
| S-EPMC6058795 | biostudies-literature
| S-EPMC3578144 | biostudies-literature
| S-EPMC4401687 | biostudies-literature
| S-EPMC9928786 | biostudies-literature